Early Clinical Data Raise the Bar for Hemophilia Gene Therapies
October 11, 2016
Several gene therapy companies reported promising early clinical data in July showing that they could restore healthy blood clotting factor levels in people with severe hemophilia.
Continue reading here.
With a call of 130 decibels, the bare-throated bellbird is a big-beaked marvel.
Autonomous blood-drawing devices could help address phlebotomist shortages.